News
Summer 2022 News Summary
Below is a summary of what happened in the EU cosmetics regulatory framework during the summer of 2022 as well as what is expected to happen in the near future.
On average, 70% of our news is listed, while updates from the last 30 days are not visible.
To get access to all content and services,
Start your Free Trial or Discover our plans.
Already a Premium member? Sign In
Working Group Meetings
SCCS WG meeting on cosmetic ingredients of July 2022
On 18 and 19 July 2022, the SCCS meeting of the Working Group (WG) on cosmetic ingredients in cosmetic products was held.
European Commission
New Threshold for Formaldehyde in cosmetic products
On 8 July 2022, Regulation (EU) 2022/1181 was published in the Official Journal of the European Union amending the preamble of Annex V to Regulation (EC) No 1223/2009 with regard to the threshold for the labelling of the warning “releases formaldehyde” in cosmetic products.
Final Opinions
Kojic Acid: Final revised SCCS opinion
The SCCS adopted the final opinion on Kojic Acid at its plenary meeting on 15–16 March 2022. The final opinion was subject to a corrigendum adopted by the SCCS on 10 June 2022. The corrigendum includes changes in the calculation of systemic exposure dose, safety assessment, and conclusion.
Requests For Opinions
Silver Zinc Zeolite: Request for SCCS opinion
The European Commission has asked the Scientific Committee to assess the safety of Silver Zinc Zeolite (with INCI name “Ammonium Silver Zinc Aluminium Silicate”) in cosmetic products. The SCCS approved this mandate in the plenary meeting on 21-22 June 2022, and the Committee has nine months to deliver its Opinion.
Final Opinions
Aluminium-containing cosmetic ingredients
Although it is easy to identify some Aluminium (AL)-cosmetic ingredients by their INCI name containing the word “Aluminum”, there are many Al-containing ingredients difficult to be identified.
Final Opinions
4-Methylbenzylidene camphor (4-MBC): Final SCCS opinion
The Scientific Committee has published its final Opinion on 4-Methylbenzylidene camphor (4-MBC). It was adopted by written procedure on 29 April 2022.
Requests For Opinions
Salicylic Acid: Request for SCCS opinion
Considering the concerns related to potential endocrine-disrupting properties of “Salicylic Acid” the European Commission has asked the Scientific Committee to assess its safety in cosmetic products. On 3 February 2022, this mandate has been accepted by the SCCS and the Committee has nine months to deliver its Opinion.
Preliminary Opinions
Alpha-arbutin and beta-arbutin: Preliminary SCCS opinion
The Scientific Committee has published the preliminary opinion on alpha-arbutin and beta-arbutin after the mandate given by the European Commission to assess their potential to release hydroquinone (HQ). Hydroquinone (CAS No. 123-31-9, EC No. 204-617-8) is prohibited as a cosmetic ingredient. The SCCS adopted this document at its plenary meeting Read more…
Preliminary Opinions
Triclocarban and Triclosan: Preliminary SCCS Scientific Advice
The Scientific Committee has published the preliminary scientific advice on Triclocarban and Triclosan as substances with potential endocrine-disrupting properties in cosmetic products. The SCCS adopted this scientific advice at its plenary meeting on 15-16 March 2022.